Scolicidal and Apoptotic Activities of 5-hydroxy-1, 4-naphthoquinone as a Potent Agent against Echinococcus granulosus Protoscoleces
authors Moghadaszadeh, M; Khayyati, M; Spotin, A; Norouzi, R; Pagheh, AS; Oliveira, SMR; Pereira, MD; Ahmadpour, E
nationality International
journal PHARMACEUTICALS
author keywords Echinococcus granulosus; scolicidal; nanoliposome; juglone; apoptotic activity
keywords IN-VITRO; ALBENDAZOLE SULFOXIDE
abstract Cystic hydatid disease (CHD) is a zoonotic disease with different clinical stages caused by the larval stage of the cestode Echinococcus granulosus. It is important to highlight as a public health problem in various regions of the world. In the current study, the efficacy and apoptotic activity of the liposomal system containing juglone (5-hydroxy-1,4-naphthoquinone) were assessed against protoscoleces (PSCs) in vitro. To this aim, firstly, liposomal vesicles were prepared by the thin-film method. Their physico-chemical features were assessed using Zeta-Sizer and Scanning Electron Microscope (SEM). Subsequently, various concentrations (50, 100, 200, 400, and 800 mu g/mL) of juglone nanoliposomes at different exposure times (15, 30, 60, and 120 min) were used against PSCs. Results showed that juglone nanoliposomes at all tested concentrations induced scolicidal effect, however, 800 mu g/mL and 400 mu g/mL of juglone nanoliposomes could reach 100% mortality in 60 and 120 min, respectively. Additionally, we found that caspase-3 mRNA expression was higher in PSCs treated with juglone nanoliposomes compared to control groups (p < 0.001). Therefore, juglone nanoliposomes are suggested to have a more potent apoptotic effect on PSCs. Generally, optimized doses of juglone nanoliposomes could display significant scolicidal effects. Moreover, further in vivo studies are required to evaluate the efficacy of this nanoliposome.
publisher MDPI
isbn 1424-8247
year published 2021
volume 14
issue 7
digital object identifier (doi) 10.3390/ph14070623
web of science category 10
subject category Chemistry, Medicinal; Pharmacology & Pharmacy
unique article identifier WOS:000676329200001
  ciceco authors
  impact metrics
journal analysis (jcr 2019):
journal impact factor 4.286
5 year journal impact factor Not Available
category normalized journal impact factor percentile 82.037
dimensions (citation analysis):
altmetrics (social interaction):



 


Apoio

1suponsers_list_ciceco.jpg